Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +12.00p +0.62% 1,945.00p 1,944.00p 1,949.00p 1,962.00p 1,890.00p 1,942.00p 171,028 11:38:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 102.2 34.3 23.9 81.5 2,241.44

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
16/11/201710:35Fevertree Drinks PLC (Fever-Tree)1,417
09/11/201709:18FEVER TREE with chart1,318
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:38:551,947.00961,869.12O
11:38:551,945.006116.70AT
11:38:461,946.5020389.30O
11:38:031,945.001011,964.45AT
11:38:031,945.0013252.85AT
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

DateSubject
20/11/2017
08:20
Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 1,933p.
Fevertree Drinks has a 4 week average price of 1,816p and a 12 week average price of 1,816p.
The 1 year high share price is 2,506p while the 1 year low share price is currently 1,002p.
There are currently 115,240,896 shares in issue and the average daily traded volume is 1,001,709 shares. The market capitalisation of Fevertree Drinks is £2,246,045,063.04.
13/11/2017
17:22
monnow: Artisan have bought a big chunk, so dropping the share price and a bit of verbal diarrhoea from press tipsters seems to have worked a treat in relieving PI's of some of their shares. Why would they stop now? if I was them I would carry on buying with this new market paradigm of the more we buy the further the share price falls ??
07/11/2017
07:34
bookbroker: They are the only high street chain in the Food and Beverage category that is actually seeing real growth, seen the share price ‘juzzer’, up about 30% this year, the rest down about as much! They sell about 20 different types of gin, not had Fever Tree tonic or coke with Veuve Cliquot before, must try it!!🤡
05/11/2017
17:50
christh: Simple..... Elementary mr Investor. A retracement same as it was £19 and dropped to £16 and then went to £25. I have a feeling this is the same pattern, so as IC said hold your nerve and BUY more on weakness. I do expect to climb up back to £22 and by Xmas up to £30 or close. Fevertree products are in great demand, well after sought,sales are high, capacity doubled to meet demand, exports are booming. So take a hint about the future share price. A trading update may be forthcoming although the results may be delayed to account for the Xmas period, the period that will boost sales. The year ends in 31 December, so will have the results in late January. If the earnings come around £180m or more then will see the price rocket.
01/11/2017
15:58
christh: The rapid growth of premium drinks brand Fever-Tree shows no sign of slowing as the posh tonic maker upgraded its profits forecasts following a 77pc spike in revenues. Fever-Tree’s share price is 15 times higher than when the company floated in late 2014, with shares spiking a further 21pc following the publication of its first-half results on Tuesday. It was last year’s best performing stock on London’s junior Aim market and has consistently smashed expectations as it capitalises on the remarkable growth in demand for gin. Chief executive Tim Warrillow said he was “delightedR21;, particularly with the company’s performance in the UK, where it enjoyed growth of 113pc in the first half of the year. Overall, revenue climbed 77pc to £71.9m, compared to £40.6m in the first half of 2016. “The really encouraging thing is that we are seeing growth across all regions,” said Mr Warrillow. “In the UK [the mixer category] is now the fastest-growing soft drink category, growing at 17pc in the first half of the year. And the statistic we are proudest of is that Fever-Tree contributed to 99pc of that growth, so it is very encouraging.” Fever-Tree’s Ebitda (earnings before interest, taxes, depreciation and amortisation) rose more than 100pc from £12.4m to £25.2m. In continental Europe, revenues rose from £13.4m last year to £22m, while US revenues climbed from £9.2m to £13.2m. “We have always felt very strongly that gin and tonic as a movement will never be a fad,” said Mr Warrillow. Fever-Tree is trying to expand its global operations Fever-Tree is trying to expand its global operations “It is fundamentally a great drink that is well loved, and all this is is an improvement on the gin and tonics that were available before. We have a whole world of fantastic different gins out there and now really good mixers to go with it.” Earlier this year, Charles Rolls, one of the company’s founders sold a stake of around 4pc in the company for more than £70m. The company has been suggested as a potential takeover target for drinks giants, but Mr Warrillow said it is just focused on further growth. “We have had this mooted from the start of our life on the public market, that they think there will be interest from spirit companies, beer companies and soft drink companies,” he said. “I am sure there is interest, but that is not something we are focused on. We are really focused on this growing opportunity that we see ahead of us.” Related Topics
27/9/2017
11:12
christh: I wrote to the directors on 15 September and received a reply the same day ---------------------------------------------------------------------- Dear Mr xxxxxxxx, I am writing to you in relation to your email to Fever-Tree this morning. Apologies it has taken some time to get back to you. The Company knows no reason for the fall in the share price and understands your frustration. What I can say in relation to current trading is that if the Company has an obligation to update the market if it has information regarding its trading that could be deemed price sensitive (both from a positive or negative standpoint). The Company’s last trading update at the end of July contained the following update from the CEO – “We are delighted to report another strong performance in the first half of 2017, continuing the momentum seen in 2016 We achieved growth in all our regions, driven by further distribution gains and underlying rate of sales growth as the two key trends of premiumisation and mixability continue to gather pace globally. “We continue to invest and improve our infrastructure, relationships with key suppliers and customers as well as adding to our senior team. The strength of our brand and first mover advantage means we are well positioned as the opportunity for premium mixers continues to gather momentum across our key markets. Given the strong performance in the first half of the year, the Board anticipates that the outcome for the full year will be materially ahead of its expectations.”” I am sorry you feel there has not been more news from the Company but I can assure you management is focused on continue to drive value for all shareholders. I would be very happy to answer any further questions you have and can be contacted on the below number or would be happy to give you a call. Regards Oliver Winters
27/9/2017
10:29
christh: Why Fevertree shares have ‘plenty more growth to come’ News 5 May 2017 Alan Rowsell, who runs the high-performing Standard Life Global Smaller Companies Fund, has revealed the reasons why he keeps owning Fevertree shares, despite the enormous share price gains. Rowsell remarked that since he bought the shares in Fevertree, which manufactures tonic waters and other drinks, they have gone up 270%. But he said, ‘we continue to own the shares because we still see a lot of growth. Fevertree has done very well since it came to market. But actually it is still only 1% of the global; spirits market, and so there is scope for a lot more growth. You couldn’t really argue that Fevertree is an undervalued, or that it is a typical value stock. But I think it will grow into its current valuation.’ Fevertree is the third largest investment in the £500 million Standard Life Global Smaller Companies fund, which has returned 113% over the past five years, compared with 80% for the average fund in the IA Global Sector in the same time period. hTtp://www.whatinvestment.co.uk/no-threat-hsbc-dividend-following-latest-results-2553582/
27/9/2017
09:28
christh: Villarich, The analysis is done by the broker house. The articles posted are such as published by the media. My own analysis based on the long term graph points upwards. The Bullish signal is somewhere between £28-£30 but maybe March/April 2018. Also based on fundementals Fevertree tends to Double-Quadruple its earnings/profits year upon year and they are doubling production to meet demand. That is a clue! The short term flactuation ,instability of the share price will change and turn. A broker said to me "Nobody knows the bottom, nobody knows the top". It could turn up any time and jump £2-£3 upwards as we all know AIM stocks are volatile. It has fallen from £25.35 on 1 September to the current value of £22. A very substantial fall which is maybe because of absence of news, ftse drop,market sentiment,currency movements. However this is an opportunity to Buy as the price is very attractive and a good return if it goes to £25-£28 or £30 anytime soon on any news. i.e. China and India expansion (see post-link)
12/9/2017
07:50
christh: Why Fevertree shares have ‘plenty more growth to come’ News 5 May 2017 Alan Rowsell, who runs the high-performing Standard Life Global Smaller Companies Fund, has revealed the reasons why he keeps owning Fevertree shares, despite the enormous share price gains. Rowsell remarked that since he bought the shares in Fevertree, which manufactures tonic waters and other drinks, they have gone up 270%. But he said, ‘we continue to own the shares because we still see a lot of growth. Fevertree has done very well since it came to market. But actually it is still only 1% of the global; spirits market, and so there is scope for a lot more growth. You couldn’t really argue that Fevertree is an undervalued, or that it is a typical value stock. But I think it will grow into its current valuation.’ Fevertree is the third largest investment in the £500 million Standard Life Global Smaller Companies fund, which has returned 113% over the past five years, compared with 80% for the average fund in the IA Global Sector in the same time period. hTtp://www.whatinvestment.co.uk/no-threat-hsbc-dividend-following-latest-results-2553582/
22/6/2017
16:07
sogoesit: The article excerpt referred to in post 1013: "Fevertree (FEVR:AIM) £16.05 Current market status: LOVED Fevertree’s tonic water is increasingly the gin lover’s mixer of choice as it is considered a high quality product. The company has succeeded in getting its products stocked in a wide range of places, from supermarkets and restaurants to airlines and pubs. Fevertree has an asset-light, outsourced production model that means it is very cash generative and able to pay a progressive dividend. Its share price has risen 12-fold in value since joining the stock market in 2014. It has developed a reputation for providing conservative earnings guidance to analysts and subsequently over-delivering when financial numbers are reported. That has led to a continuous stream of earnings upgrades which have fuelled significant share price gains. FEVR - Comparison Line Chart (Rebased to first) WHAT ARE THE NEGATIVE POINTS FOR THE INVESTMENT CASE? 1. Could struggle to crack dark spirit market It is betting on a repeat of its tonic water success in the dark spirit mixers category. We think that’s a tall order. The market could punish the share price if the company cannot crack this market to same degree as it has done with light spirit mixers. Gin (a light spirit) and tonic is a refreshing drink where consumers clearly want high quality from both the spirit and the mixer, hence why Fevertree has done so well. However, dark spirits tend to be drunk neat, such as brandy, bourbon and whisky, so no need for fancy mixers. A mixer could cover up the true taste of whisky, for example, which defeats the object of enjoying that type of spirit. Water or ice would be acceptable mixers for whisky, but you don’t need a Fevertree-branded product. As for something like whisky and cola, surely that is the preferred drink of someone who is going after quantity over quality? Fevertree is now selling Madagascan Cola, which it claims to enhance ‘the complex flavours’ of the finest rums, whiskies and bourbons. Convincing shophisticated whisky drinkers to start adding cola to their favourite tipple will be a hard sell, in our opinion. 2. Is the business really worth £1.8bn? We note that Charles Rolls, one of the company’s founders and deputy chairman, last month sold £73.1m worth of shares. He cashed in £17.3m worth of shares when the company floated three years ago, plus earned £648,000 from Fevertree in pay and bonuses in 2016 alone – so hardly short of cash. Selling a large chunk now sends a negative signal to the market about the company’s future prospects. 3. Main Market plans We’ve heard talk that Fevertree is going to move to London’s Main Market. The company’s advisers say there are no plans at present, but we see this as a short-term risk to the share price if it does happen. The stock is a popular choice for investors wanting AIM shares that qualify for inheritance tax benefits. IHT portfolio managers would be forced to sell if Fevertree went to the Main Market as the shares would no longer qualify for the tax benefits."
10/6/2017
11:13
henchard: Here are some actual numbers for 2016 and forecast numbers for 2017 and 2018 (based on the current share price of 1,714p): ..........2016.....2017.....2018 EPS.......23.86p...27.68p...31.06p Growth....106.2%...16.0%....12.2% P/E.......71.8x....61.9x....55.2x Surely the shares are way too high at these P/Es for the forecast growth. The PEG ratio for 2017 is 3.9. For the PEG to get to the "fair value" benchmark of 1 (let alone a "growth-at-a-reasonable-price" level of below 1) FEVR would have to do EPS of 35.4p in 2017, which is 28% higher than the current consensus and 22% higher than the most bullish analyst, who's forecasting 29p EPS according to the FT. I could see FEVR beating EPS forecasts but not to the extent of 35.4p or higher. The alternative, of course, is that the share price would have to fall significantly for the valuation to become attractive.
Fevertree share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20171120 11:55:31